Skip to main content
. 2015 May 14;2015:532478. doi: 10.1155/2015/532478

Figure 1.

Figure 1

CONSORT diagram. Patients who received gemcitabine + docetaxel (GD) and placebo were excluded from the toxicity and efficacy analysis of GD + bevacizumab.